JOHN GILLESPIE: Open Payments
NPI 1609984475 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 8 companies in 2025. Trend: 2023 $268 · 2024 $241 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Novo Nordisk Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: LYBALVI, FANAPT, Ozempic, Auvelity, AUSTEDO XR, OTEZLA, REXULTI, MOUNJARO.
Industry payments across KY — which companies pay providers there.
